Trans Thoracic Ultrasound to Assess Diaphragmatic Function in Stable COPD Versus Bronchial Asthma.
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
- Assessment of diaphragmatic function (excursion, thickness variation, thickness ratio) in COPD and bronchial asthma patients.
- Assessment of presence of correlation between diaphragmatic dysfunction and pulmonary function.
- Assessment of possible association between diaphragmatic dysfunction and presence of reversibility in pulmonary function post bronchodilator.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedApril 8, 2024
April 1, 2024
2 years
February 28, 2024
April 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
diaphragmatic function
Compare diaphragmatic function using ultrasound device by measuring diaphragmatic thickness in both stable COPD and bronchial asthma patients.
2 years
Secondary Outcomes (1)
pulmonary function .
2 years
Study Arms (2)
chronic obstructive pulmonary disease (COPD)
EXPERIMENTALultrasound to COPD patients to asses' diaphragmatic function.
bronchial asthma
EXPERIMENTALultrasound to bronchial asthma patients to asses' diaphragmatic function.
Interventions
5\. Transthoracic ultrasound for both right and left diaphragm during inspiration and expiration.
Eligibility Criteria
You may qualify if:
- Stable patients (not in exacerbation).
You may not qualify if:
- Patients with comorbidities as cardiac, renal or hepatic diseases.
- Patients who have combined COPD and bronchial asthma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
February 28, 2024
First Posted
April 5, 2024
Study Start
April 1, 2024
Primary Completion
April 1, 2026
Study Completion
May 1, 2026
Last Updated
April 8, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share